MKC-963

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H25N3
Molecular Weight	331.454
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](NC1=C2C=CC=CC2=C(N=N1)C3=CC=CC=C3)C4CCCCC4

InChI

InChIKey=OJBBUQUNTTVULM-MRXNPFEDSA-N

InChI=1S/C22H25N3/c1-16(17-10-4-2-5-11-17)23-22-20-15-9-8-14-19(20)21(24-25-22)18-12-6-3-7-13-18/h3,6-9,12-17H,2,4-5,10-11H2,1H3,(H,23,25)/t16-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C22H25N3
Molecular Weight	331.454
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 09:59:52 GMT 2025` Edited by `admin` on `Wed Apr 02 09:59:52 GMT 2025`
Record UNII	B83N349DUW
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MKC-963

Common Name

English

MKC 963

Preferred Name

English

1-PHTHALAZINAMINE, N-((1R)-1-CYCLOHEXYLETHYL)-4-PHENYL-

Systematic Name

English

1-PHTHALAZINAMINE, N-(1-CYCLOHEXYLETHYL)-4-PHENYL-, (R)-

Systematic Name

English

N-((1R)-1-CYCLOHEXYLETHYL)-4-PHENYL-1-PHTHALAZINAMINE

Systematic Name

English

Code System Code Type Description

PUBCHEM

9840534

Created by admin on Wed Apr 02 09:59:52 GMT 2025 , Edited by admin on Wed Apr 02 09:59:52 GMT 2025

PRIMARY

CAS

149549-14-4

Created by admin on Wed Apr 02 09:59:52 GMT 2025 , Edited by admin on Wed Apr 02 09:59:52 GMT 2025

PRIMARY

EPA CompTox

DTXSID601212836

Created by admin on Wed Apr 02 09:59:52 GMT 2025 , Edited by admin on Wed Apr 02 09:59:52 GMT 2025

PRIMARY

FDA UNII

B83N349DUW

Created by admin on Wed Apr 02 09:59:52 GMT 2025 , Edited by admin on Wed Apr 02 09:59:52 GMT 2025

PRIMARY

Related Record Type Details


					VK4SQL11C0

CYTOCHROME P450 1A2

METABOLIC ENZYME -> SUBSTRATE


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR

Name	Property Type	Parameters
Tmax	PHARMACOKINETIC	ORAL ADMINISTRATION ON DAY 1 DOSE

Biological Half-life	PHARMACOKINETIC	ORAL ADMINISTRATION ON DAY 1 DOSE